Sharp invests $11m in injectable and cold storage tech

By Flora Southey

- Last updated on GMT

(Image: Getty/NikiLitov)
(Image: Getty/NikiLitov)
Sharp will boost syringe assembly and cold storage capabilities at facilities in the US and the Netherlands.

In Allentown, US, Sharp Packaging Services has added Groninger labeling machines to its syringe assembly capacity to improve manufacturing speed and in-line safety device capabilities for its clients.

The firm will also add DEA-approved caged cold storage to the site, increasing temperature-controlled storage capacity by 61%.

At its facility in Belgium, Sharp will add Groninger labeling machines and a high-speed syringe assembly Bausch+Ströbel machine, and boost vial labeling capabilities and cold storage capacity in Oudehaske, the Netherlands.

At CPhI North America last week, senior vice president of technology and innovation Rick Seibert told us the improved services will benefit both pharmaceutical and biotech firms.

The executive has observed a shift in the market he said, from oral solid dosage forms to injection pens and pre-filled syringes, which have particular storage requirements.

The investment responds to both an immediate need from current customers, as well as to predicted increased demand from "virtual"​ companies, he said.

“As soon as our capabilities reach about 60% utilization, we invest in growth,” ​he added.

In April last year​, Sharp bought Daiichi Sankyo’s packaging facility in Bethlehem, Pennsylvania.

The firm also announced plans to invest £9m ($11.3m) in a clinical packaging facility in South Wales, UK.

Related topics Contract Manufacturing & Logistics

Related news

Show more

Follow us


View more